Beta-Blockers Fail to Deliver Secondary Prevention Benefit in Key MI Patients
Standard medications losing appeal amid more modern heart attack treatments
Stay updated with breaking news from Roxana Mehran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Standard medications losing appeal amid more modern heart attack treatments
Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities...
WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 10, 2023--
New study includes patients aged ≥65 years with atrial fibrillation (AF) at high risk for ischemic stroke or systemic embolism who are deemed ineligible for oral anticoagulant (OAC) treatment due to increased risk of bleedingOCEANIC-AFINA, the latest Phase III study in the OCEANIC clinical trial program, will invest...
Taken together, a host of neutral or underpowered studies hint at a benefit to personalizing DAPT decisions, a new review argues.